Publications Database

Accordino R. E. et al. (2016)

Psychopharmacological interventions in autism spectrum disorder.

Expert Opinion on Pharmacotherapy

May, 17(7), pp. 937-952.

Read Abstract (New Window)

Akhondzadeh S. et al. (2010)

Double-blind placebo controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

34(1), pp. 32-36

Read Abstract (New Window)

Ali G. et al. (2016)

Minocycline as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind placebo-controlled trial.

Journal of Child and Adolescent Psychopharmacology

November, 26(9), pp. 784-791.

Read Abstract (New Window)

Aman M. G. et al. (2008)

Cognitive effects of risperidone in children with autism and irritable behavior.

Journal of Child and Adolescent Psychopharmacology

18(3), pp. 227-236

Read Abstract (New Window) Read Full (New Window)

Aman M. G. et al. (2010)

Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

20(5), pp. 415-422.

Read Abstract (New Window)

Aman M. G. (2004)

Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder.

Seminars in Pediatric Neurology

11(3), pp. 225-228

Read Abstract (New Window)

Aman M. G. et al. (2015)

Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial.

Journal of Child and Adolescent Psychopharmacology

August, 25(6), pp. 482-493.

Read Abstract (New Window) Read Full (New Window)

Anagnostou E.

Clinical trials in autism spectrum disorder: evidence, challenges and future directions.

Current Opinion in Neurology

Read Abstract (New Window)

Anagnostou E. et al. (2006)

Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder.

Journal of Clinical Psychopharmacology

26(4), pp. 444-446

Anagnostou E. , Hansen R. L. (2011)

Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications.

Current Opinions in Pediatrics

23(6), pp. 621-627.

Read Abstract (New Window)

Arnold L. E. et al. (2012)

Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders.

Journal of Child and Adolescent Psychopharmacology

22(3), pp. 198-205.

Read Abstract (New Window)

Asadabadi M. et al. (2013)

Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

Psychopharmacology (Berl)

225(1), pp. 51-59.

Read Abstract (New Window)

Ashburner J. , Ziviani J. , Rodger S. (2008)

Sensory processing and classroom emotional, behavioral, and educational outcomes in children with autism spectrum disorder.

American Journal of Occupational Therapy

62(5), pp. 564-573

Read Abstract (New Window)

Baribeau D. A. , Anagnostou E. (2014)

An update on medication management of behavioral disorders in autism.

Current Psychiatry Reports

16(3), pp. 437

Read Abstract (New Window)

Baruth J. et al. (2010)

Low-frequency repetitive transcranial magnetic stimulation (rTMS) modulates evoked-gamma frequency oscillations in autism spectrum disorder (ASD).

Journal of Neuropathy

14(3), pp. 179-194.

Read Full (New Window)

Becker M. M. et al.

Improvement in symptoms of autism spectrum disorder in children with the use of gastrin-releasing peptide: An open trial.

Clinical Neuropharmacology

Read Abstract (New Window)

Bishop J. R. et al. (2015)

Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder.

Pharmacogenetics and Genomics

November, 25(11), pp. 548-554.

Read Abstract (New Window)

Blankenship K. et al. (2010)

Aripiprazole for irritability associated with autistic disorder in children and adolescents aged 6-17 years.

Pediatric Health

4(4), pp. 375-381

Read Abstract (New Window) Read Full (New Window)

Boon-Yasidhi V. et al. (2002)

Risperidone in the treatment of autistic Thai children under 4 years of age.

Journal of the Medical Association of Thailand

85 s. 784-789

Read Abstract (New Window)

Boris M. et al. (2007)

Effect of pioglitazone treatment on behavioral symptoms in autistic children.

Journal of Neuroinflammation

4(3),

Read Abstract (New Window) Read Full (New Window)